tiprankstipranks
Fulgent Genetics (FLGT)
NASDAQ:FLGT
US Market

Fulgent Genetics (FLGT) Income Statement

1,643 Followers

Fulgent Genetics Income Statement

Last quarter (Q4 2025), Fulgent Genetics's total revenue was $83.34M, an increase of 9.34% from the same quarter last year. In Q4, Fulgent Genetics's net income was $-23.42M. See Fulgent Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 322.67M$ 283.47M$ 289.21M$ 618.97M$ 992.58M
Gross Profit
$ 130.88M$ 107.22M$ 104.46M$ 366.90M$ 777.05M
Operating Expenses
$ 221.97M$ 181.13M$ 299.99M$ 188.37M$ 101.10M
Depreciation and Amortization
$ 24.12M$ 24.93M$ 26.14M$ 32.66M$ 11.00M
EBITDA
$ -45.83M$ -48.99M$ -147.45M$ 217.70M$ 686.96M
Operating Income
$ -91.10M$ -73.92M$ -195.53M$ 178.53M$ 675.95M
Other Income/Expenses
$ 21.07M$ 21.96M$ 21.44M$ 5.50M$ 5.08M
Pretax Income
$ -70.03M$ -51.96M$ -174.09M$ 184.03M$ 681.03M
Net Income
$ -60.51M$ -42.71M$ -167.82M$ 143.40M$ 507.36M
Per Share Metrics
Basic EPS
$ -1.97$ -1.41$ -5.63$ 4.76$ 17.13
Diluted EPS
$ -1.97$ -1.41$ -5.63$ 4.63$ 16.26
Weighted Average Shares Outstanding
30.78M 30.23M 29.78M 30.10M 29.41M
Weighted Average Shares Outstanding (Diluted)
30.78M 30.23M 29.78M 30.96M 30.98M
Currency in USD

Fulgent Genetics Earnings and Revenue History